CALY
Basic information
Region (hg38): 10:133324072-133336935
Previous symbols: [ "DRD1IP" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CALY gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 13 | 13 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 13 | 1 | 0 |
Variants in CALY
This is a list of pathogenic ClinVar variants found in the CALY region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-133325868-G-A | not specified | Uncertain significance (Jan 17, 2024) | ||
10-133325897-G-T | not specified | Uncertain significance (Oct 03, 2023) | ||
10-133325906-G-C | not specified | Uncertain significance (Jan 05, 2022) | ||
10-133325976-A-T | not specified | Uncertain significance (Mar 17, 2023) | ||
10-133326019-G-T | not specified | Uncertain significance (Jul 25, 2024) | ||
10-133326052-G-T | not specified | Uncertain significance (Jun 18, 2021) | ||
10-133326112-G-A | Likely benign (Jun 01, 2022) | |||
10-133326933-A-G | not specified | Uncertain significance (Nov 29, 2021) | ||
10-133326946-A-G | not specified | Uncertain significance (Sep 01, 2024) | ||
10-133326982-C-A | not specified | Uncertain significance (Aug 11, 2024) | ||
10-133327909-C-T | not specified | Uncertain significance (Nov 17, 2023) | ||
10-133327919-C-T | not specified | Uncertain significance (Apr 25, 2023) | ||
10-133328015-C-T | not specified | Uncertain significance (Mar 16, 2022) | ||
10-133328923-C-G | not specified | Uncertain significance (Apr 04, 2024) | ||
10-133328933-C-G | not specified | Uncertain significance (Dec 20, 2023) | ||
10-133328970-C-A | not specified | Uncertain significance (Jun 10, 2022) | ||
10-133328973-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
10-133328977-C-T | not specified | Uncertain significance (Oct 11, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CALY | protein_coding | protein_coding | ENST00000252939 | 4 | 11549 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0387 | 0.848 | 124728 | 0 | 3 | 124731 | 0.0000120 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.26 | 67 | 103 | 0.650 | 0.00000548 | 1375 |
Missense in Polyphen | 20 | 41.572 | 0.4811 | 489 | ||
Synonymous | 0.318 | 41 | 43.7 | 0.939 | 0.00000239 | 439 |
Loss of Function | 1.28 | 3 | 6.52 | 0.460 | 2.78e-7 | 75 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.000105 | 0.000100 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000184 | 0.0000178 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Interacts with clathrin light chain A and stimulates clathrin self-assembly and clathrin-mediated endocytosis. {ECO:0000269|PubMed:16595675}.;
- Pathway
- Dopaminergic synapse - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.131
Haploinsufficiency Scores
- pHI
- 0.154
- hipred
- N
- hipred_score
- 0.379
- ghis
- 0.573
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.245
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Caly
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); normal phenotype;
Gene ontology
- Biological process
- dopamine receptor signaling pathway;endosomal transport;positive regulation of endocytosis;clathrin coat assembly;postsynaptic neurotransmitter receptor internalization
- Cellular component
- endosome;integral component of plasma membrane;cytoplasmic vesicle membrane;cytoplasmic vesicle;postsynaptic endocytic zone;glutamatergic synapse
- Molecular function
- protein binding;clathrin light chain binding;cargo receptor activity;protein-containing complex binding